Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Contrast-Enhanced Spectral Mammography Minimizes Diagnosis Delays

By HospiMedica International staff writers
Posted on 15 Mar 2012
A new breast imaging scanning procedure has been developed to be simple: after an intravenous injection of contrast dye (similar to magnetic resonance imaging [MRI]), the patient receives a mammogram using contrast-enhanced spectral mammography (CESM) technology, which basically analyzes blood flow patterns within the breast tissue to create a precise image of normal versus abnormal findings. More...


The Pink Lotus Breast Center, a breast center focused on the prevention, screening, diagnosis, and treatment of breast cancer, announced the unveiling of GE Healthcare’s CESM technology at its flagship breast center in Beverly Hills, CA, USA. CESM will be provided at the facility’s Sheryl Crow Imaging Center--the first facility in the United States to make this new advancement available to patients.

“We expect CESM to minimize the anxiety-provoking delay between finding something on screening mammography that might be cancer, and giving a woman definitive answers with a plan,” said Kristi Funk, MD, founder of the Pink Lotus Breast Center.

When an inconclusive mammogram and ultrasound require additional testing, scheduling, and completing the next step--such as MRI--frequently creates an indirect and lengthy path that may not even lead to a diagnosis. CESM lessens this path for many patients in several ways: (1) a CESM scan only takes a little longer than a diagnostic mammogram, and uses the same equipment as a routine mammogram, which patients already understand; (2) the CESM technology clearly isolates concerning lesions while hiding noncancerous tissue, thus eliminating the ambiguity of the initial study; (3) unlike MRI, CESM is not hindered by hormone replacement or menstrual cycles, so CESM can be scheduled immediately with findings available within minutes; and (4) compared to MRI, CESM does not cause as much discomfort or claustrophobia, and is four times faster.

“More than ever before, patients who have an inconclusive mammogram can expedite their path to a diagnosis using CESM,” remarked Lori-Beth Sewell, chief operating officer at the Pink Lotus Breast Center. “This further sets us apart from other organizations that are often so departmentally fragmented that the path to diagnosis can last weeks or even longer.”

As a comprehensive breast center, the Pink Lotus Breast Center provides new technologic developments such as CESM, as well as in offering a wide variety of screening and diagnostic tools that allow patients to be quickly diagnosed, minimizing their anxiety over the unknown. This is why GE Healthcare (Chalfont St. Giles, UK) selected the Pink Lotus Breast Center to launch its CESM technology, which carries the brand name SenoBright. CESM considerably reduces patient anxieties by resolving inconclusive findings with a short wait.

Related Links:

GE Healthcare
Pink Lotus Breast Center



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Exam Table
PF400
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.